Skip to main content

Table 1 Participant baseline characteristics, N = 593

From: Patient-initiated versus fixed-interval patient-reported outcome-based follow-up in outpatients with epilepsy: a pragmatic randomized controlled trial

Variables Intention-to-treat population Per-protocol population
Intervention arm (open access telePRO):
n = 346
Control arm (standard telePRO):
n = 247
Patients who completed the open access intervention:
n = 300
Mean (SD) age, years 46.3 (17.2) 47.2 (17.3) 45.8 (17.1)
Gender: male, n (%) 182 (53) 115 (47) 164 (55)
Cohabitation status, n (%)
 Living alone 76 (22) 62 (25) 59 (20)
 Missing 12 (3) 3 (1) 12 (4)
Education, n (%)
 No or low 94 (27) 62 (25) 76 (25)
 Medium 119 (34) 96 (39) 105 (35)
 High 121 (35) 85 (34) 107 (36)
 Missing 12 (3) 4 (2) 12 (4)
Duration of epilepsy, years
 Mean (SD) 16.1 (14.3) 16.9 (15.7) 16.2 (14.4)
 Median (IQR) 12 (5–22) 12 (5–22) 11 (5–23)
 Missing, n (%) 46 (13) 29 (12) 41 (14)
Number of seizure last years, n (%)
 No seizure 235 (68) 165 (67) 213 (71)
 Seizures (1 or above) 96 (28) 69 (28) 74 (25)
 Missing 15 (4) 13 (5) 13 (4)
Side effects
 Mean (SD) 1.56 (0.79) 1.45 (0.67) 1.53 (0.76)
 Median (IQR) 1 (1–2) 1 (1–2) 1 (1–2)
 Missing, n (%) 7 (2) 2 (1) 7 (2)
Well-being (WHO-5)
 Mean (SD) 68.9 (18.9) 68.0 (19.4) 69.0 (18.9)
 Median (IQR) 72 (60–80) 72 (56–80) 72 (60–80)
 Missing, n (%) 10 (3) 3 (1) 9 (3)
General health
 Mean (SD) 2.62 (0.92) 2.64 (0.91) 2.59 (0.92)
 Median (IQR) 3 (2–3) 3 (2–3) 3 (2–3)
 Missing, n (%) 7 (2) 3 (1) 7 (2)
Social support for health (HLQ, subscale 4)
 Mean (SD) 3.30 (0.54) 3.32 (0.56) 3.30 (0.55)
 Median (IQR) 3.4 (3–3.8) 3.4 (3–3.8) 3.4 (3–3.8)
 Missing, n (%) 15 (4) 6 (2) 14 (5)
Ability to actively engage with healthcare providers (HLQ, subscale 6)
 Mean (SD) 3.87 (0.84) 3.82 (0.91) 3.87 (0.84)
 Median (IQR) 4 (3.4–4.5) 4 (3.4–4.6) 4 (3.4–4.4)
 Missing, n (%) 18 (5) 6 (2) 16 (5)
Understanding health information well enough to know what to do (HLQ, subscale 9)
 Mean (SD) 4.01 (0.79) 3.94 (0.86) 4.02 (0.77)
 Median (IQR) 4 (3.6–4.6) 4 (3.6–4.6) 4 (3.6–4.6)
 Missing, n (%) 18 (5) 6 (2) 16 (5)
Self-efficacy (GSE)
 Mean (SD) 29.35 (6.08) 29.23 (6.73) 29.71 (5.86)
 Missing, n (%) 16 (5) 7 (3) 15 (5)
  1. Differences between the arms were evaluated by chi-squared test, Wilcoxon Mann–Whitney test, or unpaired t-test. No p-value < 0.05 was found
  2. SD Standard deviation, IQR Interquartile range, WHO-5 WHO-5 well-being index, HLQ Health literacy questionnaire, GSE General self-efficacy scale
\